Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,shortLongTermDebt,changeToLiabilities,changeToOperatingActivities,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,totalCashFromFinancingActivities,issuanceOfStock,netBorrowings,WC,language,region,quoteType,triggerable,quoteSourceName,currency,market,epsCurrentYear,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,marketState,exchange,priceHint,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,epsTrailingTwelveMonths,epsForward,exchangeDataDelayedBy,shortName,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Jul 29, 2021) 4","Short Ratio (Jul 29, 2021) 4","Short % of Float (Jul 29, 2021) 4","Short % of Shares Outstanding (Jul 29, 2021) 4","Shares Short (prior month Jun 29, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry,address2
t0,EKSO,40096000.0,12655000,709000,,-1273000,,-1273000,3931000,1292000,-3348000,-3348000,,-27000,,,,0,2211000,5559000,919000,2075000,,-1273000,-1273000,244636000.0,12877000.0,40096000.0,1568000.0,52973000.0,13000.0,-204046000.0,6205000.0,-507000.0,163000.0,45938000.0,4681000.0,-507000.0,1515000.0,51295000.0,2756000.0,1991000.0,1953000.0,1428000.0,,-413000.0,-149000.0,-3601000.0,5000.0,-3606000.0,147000.0,92000.0,-497000.0,-1514000.0,,,,46614000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,us_market,-1.05,-4.571429,3.238,4.74,0.06000042,0.012658317,5.7610145,-0.9610143,-0.16681337,60744004,-4.40367,1.4823966,15,America/New_York,EDT,-14400000,False,False,4.8,1630508249,0.01999998,4.78,4.83,4.72,19705,REGULAR,NCM,4,0.41840962,4.72 - 4.83,4.78,4.81,4.84,10,9,finmb_206802444,NasdaqCM,"Ekso Bionics Holdings, Inc.",USD,101250,64766,0.84000015,0.21212125,3.96 - 14.98,-10.179999,-0.67957276,3.96,14.98,1585094400,1619726400,1635364800,1635796800,-2.02,-1.09,0,"Ekso Bionics Holdings, Inc.",2.05,,,14.98,3.96,4.74,5.761,101.25k,64.77k,12.65M,,11.14M,3.23%,16.95%,272.89k,3.55,2.16%,2.16%,212.76k,,,,,,0.00%,"Mar 24, 2020",,1:15,"Mar 24, 2020","Dec 30, 2020","Jun 29, 2021",-69.75%,-126.36%,-19.44%,-32.28%,9.27M,0.93,-2.30%,5.07M,-11.14M,-6.47M,-2.0200,,45.94M,3.63,2.5M,6.25,10.96,3.24,-8.62M,-3.41M,Value,94804,Healthcare,39,"Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation and OttoBock Healthcare Product GmbH. The company was founded in 2005 and is headquartered in Richmond, California.",Richmond,510 984 1761,CA,1609372800,United States,http://www.eksobionics.com,86400,1414 Harbour Way South,Medical Instruments & Supplies,Suite 1201
t-1,EKSO,40975000.0,12655000,603000,,-3670000,,-3670000,3771000,1235000,-3139000,-3139000,,-26000,,,,0,1910000,5049000,675000,-531000,,-3670000,-3670000,244117000.0,15529000.0,40975000.0,1646000.0,56504000.0,13000.0,-202773000.0,7187000.0,-382000.0,235000.0,49539000.0,5981000.0,-382000.0,1664000.0,54605000.0,2276000.0,2262000.0,2154000.0,1652000.0,814000.0,-14000.0,-63000.0,36677000.0,-35000.0,-2000000.0,126000.0,-228000.0,917000.0,931000.0,38712000.0,38712000.0,,48624000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,us_market,-1.05,-4.571429,3.238,4.74,0.06000042,0.012658317,5.7610145,-0.9610143,-0.16681337,60744004,-4.40367,1.4823966,15,America/New_York,EDT,-14400000,False,False,4.8,1630508249,0.01999998,4.78,4.83,4.72,19705,REGULAR,NCM,4,0.41840962,4.72 - 4.83,4.78,4.81,4.84,10,9,finmb_206802444,NasdaqCM,"Ekso Bionics Holdings, Inc.",USD,101250,64766,0.84000015,0.21212125,3.96 - 14.98,-10.179999,-0.67957276,3.96,14.98,1585094400,1619726400,1635364800,1635796800,-2.02,-1.09,0,"Ekso Bionics Holdings, Inc.",2.05,,,14.98,3.96,4.74,5.761,101.25k,64.77k,12.65M,,11.14M,3.23%,16.95%,272.89k,3.55,2.16%,2.16%,212.76k,,,,,,0.00%,"Mar 24, 2020",,1:15,"Mar 24, 2020","Dec 30, 2020","Jun 29, 2021",-69.75%,-126.36%,-19.44%,-32.28%,9.27M,0.93,-2.30%,5.07M,-11.14M,-6.47M,-2.0200,,45.94M,3.63,2.5M,6.25,10.96,3.24,-8.62M,-3.41M,Value,94804,Healthcare,39,"Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation and OttoBock Healthcare Product GmbH. The company was founded in 2005 and is headquartered in Richmond, California.",Richmond,510 984 1761,CA,1609372800,United States,http://www.eksobionics.com,86400,1414 Harbour Way South,Medical Instruments & Supplies,Suite 1201
t-2,EKSO,4434000.0,12655000,175000,,-3976000,,-3976000,4183000,1361000,-2997000,-2997000,,-26000,,,,0,2254000,5251000,893000,-979000,,-3976000,-3976000,204376000.0,16163000.0,4434000.0,1684000.0,20597000.0,8000.0,-199103000.0,7881000.0,-847000.0,320000.0,12862000.0,4974000.0,-847000.0,1857000.0,18420000.0,3389000.0,3075000.0,1978000.0,1501000.0,,-268000.0,-389000.0,-1687000.0,53000.0,-1740000.0,155000.0,11000.0,1039000.0,1687000.0,38712000.0,38712000.0,,13446000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,us_market,-1.05,-4.571429,3.238,4.74,0.06000042,0.012658317,5.7610145,-0.9610143,-0.16681337,60744004,-4.40367,1.4823966,15,America/New_York,EDT,-14400000,False,False,4.8,1630508249,0.01999998,4.78,4.83,4.72,19705,REGULAR,NCM,4,0.41840962,4.72 - 4.83,4.78,4.81,4.84,10,9,finmb_206802444,NasdaqCM,"Ekso Bionics Holdings, Inc.",USD,101250,64766,0.84000015,0.21212125,3.96 - 14.98,-10.179999,-0.67957276,3.96,14.98,1585094400,1619726400,1635364800,1635796800,-2.02,-1.09,0,"Ekso Bionics Holdings, Inc.",2.05,,,14.98,3.96,4.74,5.761,101.25k,64.77k,12.65M,,11.14M,3.23%,16.95%,272.89k,3.55,2.16%,2.16%,212.76k,,,,,,0.00%,"Mar 24, 2020",,1:15,"Mar 24, 2020","Dec 30, 2020","Jun 29, 2021",-69.75%,-126.36%,-19.44%,-32.28%,9.27M,0.93,-2.30%,5.07M,-11.14M,-6.47M,-2.0200,,45.94M,3.63,2.5M,6.25,10.96,3.24,-8.62M,-3.41M,Value,94804,Healthcare,39,"Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation and OttoBock Healthcare Product GmbH. The company was founded in 2005 and is headquartered in Richmond, California.",Richmond,510 984 1761,CA,1609372800,United States,http://www.eksobionics.com,86400,1414 Harbour Way South,Medical Instruments & Supplies,Suite 1201
t-3,EKSO,8401000.0,12655000,599000,,2452000,,2452000,3446000,1813000,-2232000,-2232000,,-23000,,,,0,2897000,5129000,1084000,4684000,,2452000,2452000,203905000.0,15085000.0,8401000.0,1654000.0,23486000.0,8000.0,-195127000.0,6400000.0,-385000.0,118000.0,14549000.0,5233000.0,-385000.0,1819000.0,21549000.0,4450000.0,3079000.0,2180000.0,1813000.0,,118000.0,590000.0,1289000.0,15000.0,-1270000.0,145000.0,221000.0,-705000.0,-4095000.0,2544000.0,2549000.0,-5000.0,16316000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,us_market,-1.05,-4.571429,3.238,4.74,0.06000042,0.012658317,5.7610145,-0.9610143,-0.16681337,60744004,-4.40367,1.4823966,15,America/New_York,EDT,-14400000,False,False,4.8,1630508249,0.01999998,4.78,4.83,4.72,19705,REGULAR,NCM,4,0.41840962,4.72 - 4.83,4.78,4.81,4.84,10,9,finmb_206802444,NasdaqCM,"Ekso Bionics Holdings, Inc.",USD,101250,64766,0.84000015,0.21212125,3.96 - 14.98,-10.179999,-0.67957276,3.96,14.98,1585094400,1619726400,1635364800,1635796800,-2.02,-1.09,0,"Ekso Bionics Holdings, Inc.",2.05,,,14.98,3.96,4.74,5.761,101.25k,64.77k,12.65M,,11.14M,3.23%,16.95%,272.89k,3.55,2.16%,2.16%,212.76k,,,,,,0.00%,"Mar 24, 2020",,1:15,"Mar 24, 2020","Dec 30, 2020","Jun 29, 2021",-69.75%,-126.36%,-19.44%,-32.28%,9.27M,0.93,-2.30%,5.07M,-11.14M,-6.47M,-2.0200,,45.94M,3.63,2.5M,6.25,10.96,3.24,-8.62M,-3.41M,Value,94804,Healthcare,39,"Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation and OttoBock Healthcare Product GmbH. The company was founded in 2005 and is headquartered in Richmond, California.",Richmond,510 984 1761,CA,1609372800,United States,http://www.eksobionics.com,86400,1414 Harbour Way South,Medical Instruments & Supplies,Suite 1201
